Table 2 Clinical data of all Crohn's disease patients at initial and follow-up scan
Characteristics | Baseline (n = 49) | Follow-up (n = 49) | p-value |
|---|---|---|---|
Montreal classification | |||
Age at diagnosis, n (%) | |||
A1 | 11 (22.4) | ||
A2 | 34 (69.4) | ||
A3 | 4 (8.2) | ||
Location, n (%) | 0.93 | ||
L1 | 17 (34.7) | 15 (30.6) | |
L2 | 1 (2.0) | 2 (4.1) | |
L3 | 30 (61.2) | 31 (63.3) | |
L3 + 4 | 1 (2.0) | 1 (2.0) | |
Behaviour, n (%) | 0.93 | ||
B1 | 31 (63.3) | 28 (57.1) | |
B2 | 11 (22.4) | 13 (26.5) | |
B3 | 5 (10.2) | 6 (12.2) | |
B2 + 3 | 2 (4.1) | 2 (4.1) | |
Perianal disease, n (%) | 28 (57.1) | 29 (59.2) | 1.00 |
BMI, kg/m2 (mean ± SD) | 18.27 ± 3.04 | 19.55 ± 2.66 | < 0.001 |
BMI classification, n (%) | 0.047 | ||
Normal | 18 (36.7) | 28 (57.1) | |
Underweight | 29 (59.2) | 21 (42.9) | |
Overweight | 2 (4.1) | 0 | |
Laboratory findings (mean ± SD) | |||
CRP, mg/L (n = 46) | 35.34 ± 43.39 | 11.71 ± 20.98 | < 0.001 |
ESR, mm/h (n = 48) | 23.85 ± 17.97 | 11.04 ± 13.51 | < 0.001 |
Alb, g/L (n = 46) | 38.43 ± 5.85 | 42.19 ± 5.42 | < 0.001 |
HCT, % (n = 47) | 34.70 ± 6.15 | 38.71 ± 5.71 | < 0.001 |